imipramina on NA
![]() | VII | 274 | 45.62% | 380 | 467 | 178 | 0.61 | 30.66% | — | — | −44% | |||
![]() | IV | 231 | 43.29% | 38 | 71 | 46 | 0.26 | 31.17% | — | — | −73% | |||
![]() | III | 228 | 45.18% | 44 | 92 | 48 | 0.44 | 26.32% | — | — | −82% | |||
![]() | VI | 213 | 43.66% | 304 | 314 | 140 | 0.43 | 16.43% | — | — | −45% | |||
![]() | V | 203 | 40.39% | 128 | 164 | 95 | 0.44 | 24.14% | — | — | −66% | |||
![]() | IV | 179 | 37.43% | — | 77 | 27 | 0.30 | 16.76% | — | — | −79% | |||
![]() | V | 119 | 50.42% | 486 | 297 | 53 | 0.49 | 42.02% | — | — | −41% | |||
![]() | VI | 109 | 40.37% | 297 | 359 | 37 | 0.44 | 37.61% | — | — | −48% | |||
![]() | V | 103 | 35.92% | 286 | 248 | 69 | 0.49 | 23.30% | — | — | −42% | |||
![]() | III | 85 | 52.94% | 258 | 102 | 24 | 0.42 | 36.47% | — | — | −50% | |||
![]() | VIII | 81 | 40.74% | 180 | 398 | 188 | 0.36 | 33.33% | — | — | −60% | |||
![]() | IV | 80 | 53.75% | 353 | 150 | 48 | 0.42 | 42.50% | — | — | −52% | |||
![]() | III | 79 | 37.97% | — | 63 | 31 | 0.35 | 21.52% | — | — | −77% | |||
![]() | III | 77 | 46.75% | 48 | 25 | 4 | 0.14 | 25.97% | — | — | −89% | |||
![]() | IV | 47 | 42.55% | 43 | 105 | 44 | 0.45 | 23.40% | — | — | −62% | |||
![]() | VII | 32 | 37.50% | 266 | 464 | 128 | 0.41 | 31.25% | — | — | −50% | |||
![]() | II | 31 | 25.81% | 107 | 77 | 14 | 0.42 | 19.35% | — | — | −55% | |||
![]() | II | 30 | 60.00% | 164 | 32 | — | 0.30 | 26.67% | — | — | −85% | |||
![]() | III | 29 | 37.93% | 2 | 57 | 52 | 0.31 | 10.34% | — | — | −71% | |||
![]() | I | 27 | 37.04% | 34 | 55 | 17 | 0.52 | 14.81% | — | — | −62% | |||
![]() | III | 24 | 45.83% | 58 | 76 | 33 | 0.21 | 16.67% | — | — | −43% | |||
![]() | III | 23 | 56.52% | 161 | 84 | 20 | 0.70 | 30.43% | — | — | −63% | |||
![]() | II | 20 | 35.00% | — | 11 | 2 | 0.05 | 20.00% | — | — | −92% | |||
![]() | II | 19 | 47.37% | 60 | 41 | 33 | 0.21 | 5.26% | — | — | −65% | |||
![]() | II | 19 | 36.84% | — | 0 | — | 0.00 | 21.05% | — | — | −100% |